HYDERABAD, FEBRUARY 05, 2024: Hydrogen Peroxide Solution, which is used as an Antiseptic and for various other therapeutic purposes, is a ‘drug’ under Drugs and Cosmetics Act and shall comply with the standards laid down in the current edition of Indian Pharmacopoeia i.e. IP-2022.
The drug ‘Hydrogen Peroxide Solution 6%’ is under price control as per Drugs (Prices Control) Order, 2013 and hence its MRP shall be in accordance with the Ceiling Price fixed by National Pharmaceutical Pricing Authority (NPPA).
In an official release here on Monday, DCA Directot-General VB Kamalasan Reddy said that that the DCA officials have noticed that ‘Hydrogen Peroxide solution’ which is labeled as ‘laboratory reagent’ is being sold by the retail medical shops to the patients, contravening the provisions of Drugs and Cosmetics Act. Hydrogen Peroxide Solution sold to the patients shall be in conformance with the standards laid down in the Indian Pharmacopoeia and shall bear the product name as ‘Hydrogen Peroxide Solution IP’ mandatorily, he stated
Further, MRP of the ‘Hydrogen Peroxide Solution IP’ sold to the patients shall be in accordance with the ‘Ceiling Price’ fixed by NPPA under Drugs (Prices Control) Order, 2013. Retail medical shops and manufacturers of Hydrogen Peroxide Solution shall strictly adhere to the requirements mentioned above. Stringent action shall be taken as per the law against violators, he warned.
